Connect2Move: Valorization of Natural Cardio Trekking Hiking Trails
Connect2Move
2 other identifiers
observational
144
1 country
1
Brief Summary
Regular exercise improves performance and reduces the risk of cardiovascular disease. Endurance and strength training are therefore forms of therapy with a high level of evidence in the prevention and rehabilitation of cardiovascular diseases. In this context, Hiking has a special role, as endurance exercise not only has a cardio-preventive effect, but also other health-promoting effects can be achieved through exercise in nature. However, intense physical activity can also trigger cardiovascular events, especially in poorly trained people. Hiking shows a particularly high rate of cardiovascular events including death. In addition to the incorrect assessment of the cardiovascular risk profile and physical performance, weather conditions (temperature, wind, precipitation) are often not included in the planning, which in combination further increases the risk of accidents. Hikers are rarely aware of the increased risk and prevent it through preventive medical examinations. Heart health can be assessed through a stress test or ergometry and at the same time endurance performance can be determined in the laboratory and training recommendations can be given based on the results. In order to use hiking specifically to prevent cardiovascular diseases and to reduce the risk of hiking accidents, this study sets the following goals:
- 1.Development, validation and dissemination of a standardized 1km cardio trekking test trail to record the individual physical endurance performance (= cardio profile), with the aim of personal categorization / determination of the stress intensities when walking and hiking on medium-sized hiking trails and alpine pastures .
- 2.Scientific conception and mapping of individual cardio profile standard routes through application-based data evaluation (digital cardio profile app) of the cardio trekking test trail for hiking tours in the partner regions Werfenweng and Aschau im Chiemgau.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 26, 2022
CompletedFirst Posted
Study publicly available on registry
February 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedJanuary 9, 2025
January 1, 2022
1.7 years
January 26, 2022
January 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Development, validation and dissemination of a standardized 1 km Cardio-Trekking-Test Trail to record the individual physical endurance capacity
The primary research aim is to answer the following research question: Development, validation and dissemination of a standardized 1 km Cardio-Trekking-Test Trail to record the individual physical endurance capacity (= CardioProfil), with the aim of personal categorization / determination of the stress intensities when walking and hiking on medium-sized hiking trails and alpine pastures
2 days
Secondary Outcomes (1)
Scientific conception and mapping of cardio profile standard routes through application-based data evaluation (digital cardio profile application) of the cardio trekking test trails
1 day
Study Arms (1)
Healthy adults
Inclusion criteria: both, mals and female, age 45 years and older. Exclusion criteria: Medical contraindications for a maximum stress test and endurance test by the attending physician Pathologies in the context of the preliminary examinations: * Acute and chronic cardiovascular diseases except arterial hypertension (systolic blood pressure ≥140 mmHg and diastolic blood pressure ≥90 mmHg in untreated and drug-treated participants) and minor valve insufficiency * Acute and chronic lung diseases * Liver and kidney diseases * diabetes mellitus * Alcohol (\> 30g / day) or drug abuse * Obesity from grade 2 (body mass index\> 35 kg / m²) * Orthopedic diseases with reduced physical performance * Existing pregnancy
Interventions
The study is divided into three examinations days, which extend over a maximum of 2 weeks: * Day 1: Inclusion examination, time required: 1.5 hours Taking anamnesis, medical examination and blood drawing, determination of PROCAM score, Framingham score, ESC score, anthropometric measurements, questionnaires (IPAQ-physical activity, health status / quality of life (SF 36)), pulmonary function test, resting ECG, echocardiography, heart rate variability measurement (VO2max determination), spiroergometry (modified Bruce protocol) on the treadmill incl. inquiries about the BORG scale * Day 2: 1 km test trail, Time required: 1 hour: Completion of a 1 km cardio test path including mobile spiroergometry * Day 3: 8 km hike, time required approx. 3.5 hours: Participation in a guided cardio hike over 8 km, if applicable, including spiroergometry Afterwards (In Austria only): Logging of physical activity, physical motivation and accompanying circumstances over a period of 3 weeks
General cardio hikes (WITHOUT spirometric breathing gas analysis) on the selected hiking trails. Measurement of the heart rate as well as the route, time and walking speed using GPS geotracking using an anonymized user profile. User survey regarding the user-friendliness of the application.
Eligibility Criteria
Healthy adults
You may qualify if:
- healthy adults
You may not qualify if:
- Medical contraindications for a maximum stress test and endurance test by the attending physician
- Pathologies in the context of the preliminary examinations:
- Acute and chronic cardiovascular diseases except arterial hypertension (systolic blood pressure ≥140 mmHg and diastolic blood pressure ≥90 mmHg in untreated and drug-treated participants) and minor valve insufficiency
- Acute and chronic lung diseases
- Liver and kidney diseases
- diabetes mellitus
- Alcohol (\> 30g / day) or drug abuse
- Obesity from grade 2 (body mass index\> 35 kg / m²)
- Orthopedic diseases with reduced physical performance
- Existing pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Technical University of Munichlead
- Ludwig Boltzmann Institute for Digital Health and Preventioncollaborator
- Paracelsus Medical Universitycollaborator
- Salzburg Research Forschungsgesellschaft mbHcollaborator
- Klinik St. Irmingard - Fachklinik für Onkologie, Kardiologie, Psychosomatik und Psychotraumatologiecollaborator
Study Sites (1)
Technical University of Munich
Munich, Bavaria, 80992, Germany
Related Publications (2)
Eisenberger L, Mayr B, Beck M, Venek V, Kranzinger C, Menzl A, Jahn I, Sareban M, Oberhoffer-Fritz R, Niebauer J, Bohm B. Assessment of Exercise Intensity for Uphill Walking in Healthy Adults Performed Indoors and Outdoors. Int J Environ Res Public Health. 2022 Dec 12;19(24):16662. doi: 10.3390/ijerph192416662.
PMID: 36554543DERIVEDMayr B, Beck M, Eisenberger L, Venek V, Kranzinger C, Menzl A, Reich B, Hornung-Prahauser V, Oberhoffer-Fritz R, Bohm B, Niebauer J. Valorization of Natural Cardio Trekking Trails Through Open Innovation for the Promotion of Sustainable Cross-generational Health-Oriented Tourism in the Connect2Move Project: Protocol for a Cross-sectional Study. JMIR Res Protoc. 2022 Jul 13;11(7):e39038. doi: 10.2196/39038.
PMID: 35830223DERIVED
Related Links
Biospecimen
Whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2022
First Posted
February 7, 2022
Study Start
August 1, 2020
Primary Completion
April 30, 2022
Study Completion
June 30, 2022
Last Updated
January 9, 2025
Record last verified: 2022-01